Consequences of low plasma histidine in chronic kidney disease patients: Associations with inflammation, oxidative stress, and mortality

American Journal of Clinical Nutrition

Volumn 87, Issue 6, 2008, Pages 1860-1866

  Watanabe, Makoto ^a   Suliman, Mohamed E ^a   Qureshi, Abdul Rashid ^a   Garcia Lopez, Elvia ^a   Bárány, Peter ^a   Heimbürger, Olof ^a   Stenvinkel, Peter ^a   Lindholm, Bengt ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALBUMIN; AMINESS N; AMINO ACID; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; DIURETIC AGENT; ERYTHROPOIETIN; FETUIN A; FIBRINOGEN; HEMOGLOBIN S; HISTIDINE; INTERLEUKIN 6; PHOSPHATE; POTASSIUM DERIVATIVE; SCATTER FACTOR; SOMATOMEDIN C;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AMINO ACID SUBSTITUTION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHI SQUARE TEST; CHRONIC KIDNEY DISEASE; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRIP STRENGTH; HUMAN; INFLAMMATION; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; OXIDATIVE STRESS; PROTEIN CALORIE MALNUTRITION; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

EID: 45749138295     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/87.6.1860     Document Type: Article

References (39)

1. Divino Filho JC, Barany P, Stehle P, Furst P, Bergström J. Free amino-acid levels simultaneously collected in plasma, muscle, and erythrocytes of uraemic patients. Nephrol Dial Transplant 1997;12:2339-48.
2. Bergström J, Alvestrand A, Furst P. Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 1990;38:108-14.
3. Tizianello A, Deferrari G, Garibotto G, Robaudo C, Saffioti S, Pontremoli R. Amino acid imbalance in patients with chronic renal failure. Contrib Nephrol 1989;75:185-93.
4. Furst P. Amino acid metabolism in uremia. J Am Coll Nutr 1989;8:310-23.
5. Flugel-Link RM, Jones MR, Kopple JD. Red cell and plasma amino acid concentrations in renal failure. JPEN J Parenter Enteral Nutr 1983;7:450-6.
6. Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, Coburn JW. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 1982;36:395-402.
7. Alvestrand A, Furst P, Bergstrom J. Plasma and muscle free amino acids in uremia: influence of nutrition with amino acids. Clin Nephrol 1982;18:297-305.
8. Visek WJ. An update of concepts of essential amino acids. Annu Rev Nutr 1984;4:137-55.
9. Bergström J, Furst P, Josephson B, Noree LO. Improvement of nitrogen balance in a uremic patient by the addition of histidine to essential amino acid solutions given intravenously. Life Sci II 1970;9:787-94.
10. Kopple JD, Swendseid ME. Evidence that histidine is an essential amino acid in normal and chronically uremic man. J Clin Invest 1975;55:881-91.
11. Pisarenko OI. Mechanisms of myocardial protection by amino acids: facts and hypotheses. Clin Exp Pharmacol Physiol 1996;23:627-33.
12. Kalant N, McCormick S. Inhibition by serum components of oxidation and collagen-binding of low-density lipoprotein. Biochim Biophys Acta 1992;1128:211-9.
13. Suliman ME, Qureshi AR, Stenvinkel P, et al. Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. Am J Clin Nutr 2005;82:342-9.
14. Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-911.
15. Kult J. The action of histidine supplementation on plasma protein metabolism in uremia. In: Kluthe R, Katz NR, eds. Histidine: metabolism, clinical aspects and therapeutic use. First International workshop. Freiburg, Germany: Georg Thieme Publishers Stuttgart, 1978.
16. Czekalski S, Hozejowski R. Intradialytic amino acids supplementation in hemodialysis patients with malnutrition: results of a multicenter cohort study. J Ren Nutr 2004;14:82-8.
17. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995;345:293-5.
18. Tomiya T, Omata M, Fujiwara K. Branched-chain amino acids, hepatocyte growth factor and protein production in the liver. Hepatol Res 2004;30S:14-18.
19. Tomiya T, Inoue Y, Yanase M, et al. Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochem Biophys Res Commun 2002;297:1108-11.
20. Tomiya T, Omata M, Fujiwara K. Significance of branched chain amino acids as possible stimulators of hepatocyte growth factor. Biochem Biophys Res Commun 2004;313:411-6.
21. Sugimura K, Kim T, Goto T, et al. Serum hepatocyte growth factor levels in patients with chronic renal failure. Nephron 1995;70:324-8.
22. Malatino LS, Mallamaci F, Benedetto FA, et al. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis 2000;36:945-52.
23. Qureshi AR, Alvestrand A, Danielsson A, et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998;53:773-82.
24. Bergström J, Heimbürger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int 1998;18:467-73.
25. Frisancho AR. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr 1984;40:808-19.
26. Suliman ME, Anderstam B, Bergstrom J. Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients. Kidney Int 1996;50:1713-7.
27. Kopple JD. Pathophysiology of protein-energy wasting in chronic renal failure. J Nutr 1999;129(suppl):247S-51S.
28. Tanaka S. [Physiological function mediated by histamine synthesis]. Yakugaku Zasshi 2003;123:547-59 (in Japanese).
29. Son DO, Satsu H, Shimizu M. Histidine inhibits oxidative stress- and TNF-alpha-induced interleukin-8 secretion in intestinal epithelial cells. FEBS Lett 2005;579:4671-7.
30. Stifel FB, Herman RH. Is histidine an essential amino acid in man? Am J Clin Nutr 1972;25:182-5.
31. Funakoshi H, Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 2003;327:1-23.
32. Uchida K. Histidine and lysine as targets of oxidative modification. Amino Acids 2003;25:249-57.
33. Babizhayev MA, Seguin MC, Gueyne J, Evstigneeva RP, Ageyeva EA, Zheltukhina GA. L-Carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical- scavenging and lipid-peroxidase activities. Biochem J 1994;304(Pt 2):509-16.
34. Lee YT, Hsu CC, Lin MH, Liu KS, Yin MC. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur J Pharmacol 2005;513:145-50.
35. Chan WK, Decker EA, Chow CK, Boissonneault GA. Effect of dietary carnosine on plasma and tissue antioxidant concentrations and on lipid oxidation in rat skeletal muscle. Lipids 1994;29:461-6.
36. Maynard LM, Boissonneault GA, Chow CK, Bruckner GG. High levels of dietary carnosine are associated with increased concentrations of carnosine and histidine in rat soleus muscle. J Nutr 2001;131:287-90.
37. Cho ES, Anderson HL, Wixom RL, Hanson KC, Krause GF. Long-term effects of low histidine intake on men. J Nutr 1984;114:369-84.
38. Reeves RD, Barbour GL, Robertson CS, Crumb CK. Failure of histidine supplementation to improve anemia in chronic dialysis patients. Am J Clin Nutr 1977;30:579-81.
39. Blumenkrantz MJ, Shapiro DJ, Swendseid ME, Kopple JD. Histidine supplementation for treatment of anaemia of uraemia. Br Med J 1975;2:530-3.